Latest Breaking News On - Cue biopharma inc - Page 8 : comparemela.com

Cue Biopharma, Inc (NASDAQ:CUE) Q2 2023 Earnings Call Transcript

Operator: Greetings, and welcome to the Cue Biopharma Investor Update Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the presentation.

Matteo levisettiKerri millarMichael dustinKaren benjaminDan passeriPiper sandlerTed tenthoffBiggest helium companiesNational academy of scienceMono pharmaceuticalsUniversity of oxfordCue biopharma incSociety for immunotherapy of cancerCue biopharmaCall transcript augustCue biopharma investor update

Cue Biopharma Reports Second Quarter 2023 Financial Results and Recent Business Highlights

Cue Biopharma Reports Second Quarter 2023 Financial Results and Recent Business Highlights
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDaniel passeriMaya romanchuckMarie campinellSecurities exchangeDrug administrationCorporate communicationsAmerican society of clinical oncologySociety for immunotherapy of cancerLifesci communicationsOno pharmaceutical co ltdCue biopharma incClinical oncologyAnnual meetingWilm tumorConsolidated statement

Cue Biopharma to Host Business Update Call and Webcast

Cue Biopharma to Host Business Update Call and Webcast
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

United statesCue biopharma incWilm tumor

Short Interest in Cue Biopharma, Inc (NASDAQ:CUE) Grows By 142 2%

Cue Biopharma, Inc. (NASDAQ:CUE – Get Free Report) was the target of a significant increase in short interest in the month of June. As of June 30th, there was short interest totalling 1,950,000 shares, an increase of 142.2% from the June 15th total of 805,200 shares. Based on an average daily trading volume, of 360,000 […]

Stifel nicolausCue biopharma incMillennium managementBlackrock incVanguard group incDimensional fund advisorsRenaissance technologiesCue biopharmaGet free reportFund advisorsCue biopharma dailyNasdaq cue

Cue Biopharma, Inc (NASDAQ:CUE) Short Interest Up 36 2% in May

Cue Biopharma, Inc. (NASDAQ:CUE – Get Rating) saw a significant increase in short interest in May. As of May 31st, there was short interest totalling 731,600 shares, an increase of 36.2% from the May 15th total of 537,100 shares. Based on an average trading volume of 243,300 shares, the days-to-cover ratio is currently 3.0 days. […]

Stifel nicolausPetera kienerMirabella financial servicesCue biopharma company profileSigma planning corpSecurities exchange commissionDimensional fund advisorsSwiss national bankCue biopharma incCue biopharmaGet ratingDirector peterExchange commissionFund advisorsGate managerPlanning corp